InvivoGen
From Wikipedia, the free encyclopedia
 |
This article is orphaned as few or no other articles link to it. Please help introduce links in articles on related topics. (December 2007) |
| InvivoGen
|
|
|---|---|
| Type | Private Corporation |
| Founded | 1997 |
| Location | San Diego, CA, USA |
| Key people | Gerard Tiraby Founder and President |
| Industry | Manufacturing |
| Product Categories | Cell Culture & Transfection, Cloning & Gene Expression, RNA Interference, Toll-Like Receptors, Cytokine Signaling |
| Website | http://www.invivogen.com/ |
Invivogen is a manufacturer of life science research products. It is based in San Diego, California and conducts business worldwide. InvivoGen is a provider of Toll-Like Receptor ligands and mycoplasma detection & elimination products. To date, about 637 academic papers cite InvivoGen's products.
[edit] History
Invivogen was founded in 1997. The company is known for its mycoplasma removal agents and its toll-like receptor product line. Although its first products focused on gene therapy, the company now produces research tools for immunology, cancer research, RNA interference, cell culture & transfection, and cloning & gene expression.
